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CLEAVAGE OF PHOSPHATE ESTER BONDS 
BY USE OF NOVEL GROUP 13 CHELATE 
COMPOUNDS 
TECHNICAL FIELD 
The present invention relates generally to novel com 
pounds, compositions and methods for the cleavage of 
phosphate ester bonds. 
BACKGROUND OF THE INVENTION 
Chemical Warfare agents such as Sarin gas and VX and 
pesticides/insecticides such as chloropyrifos, paraoxon and 
parathion exhibit extreme toxicity. Each of these compounds 
includes a phosphate ester bond. Such compounds irrevers 
ibly block a serine hydroxy group in the cellular enZyme 
acetylcholinesterase by phosphorylation, thereby disrupting 
a cell’s neurological function. 
The safe destruction of such compounds is of great 
environmental concern. Accordingly, substantial effort has 
been devoted to development of methods for decontamina 
tion of such nerve agents, pesticides and insecticides. 
ToWard that end, the cleavage of the P4OiC bond in these 
compounds has been targeted as a method of decontamina 
tion. Many such methods use d-block metals such as cobalt, 
copper, and Zinc. It is also knoWn to destroy nerve agents by 
hydrolyZing them using basic solutions and/or bleach to 
oxidiZe them to less toxic inorganic phosphates and alkali. 
HoWever, these solutions are caustic and should only be 
handled under carefully controlled conditions. Large 
excesses of bleach and/or bases are required for successful 
decontamination, and the active agent (chlorine) in bleach 
decreases With time. Bases and bleach are also not selective 
for nerve agents, and readily undergo undesirable and poten 
tially explosive side reactions. In addition, bleach is corro 
sive to surfaces of many materials it contacts. 
There is accordingly identi?ed a need in the art for a 
successful deactivating/destroying agent for such toxic 
nerve agents as nerve gas (Sarin gas, VX, and the like) and 
organophosphate pesticides. Such an agent should (a) be 
easily synthesiZed from inexpensive reagents, (b) be soluble 
in the same solvents as the nerve gases/pesticides, (c) be 
selective for the nerve agents, (d) not readily undergo 
unWanted side effects upon reaction With the nerve agents, 
and (e) be substantially non-toxic. Signi?cantly, such a 
deactivating/destroying agent Will also be useful in deacti 
vating or destroying other organic or biological agents that 
include phosphate ester bonds. 
SUMMARY OF THE INVENTION 
In accordance With the purposes of the present invention 
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But tBu But tBu 
Wherein R:alkyl, aryl or alkylaryl, X:a group 13 element 








Alternatively, the novel compound may be described as 
comprising 
N N 
/ \ \/><\/ o | 0 
Y 
But tBu But tBu 
Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
X:aluminum, gallium, indium or thallium and Y:a halide, 
a chlorate or a nitrate. 
In yet another alternative the compound of the present 
invention may be described as comprising a general formula 
(LX)nY Wherein X is selected from a group consisting of 
aluminum, gallium, indium and thallium; Y is selected from 
a group consisting of a halide, a chlorate, a sulfate and a 
nitrate; and L is a chelating ligand containing tWo nitrogen 
and tWo oxygen donor groups Where n:l or 2. The ligand 
framework provides tWo covalent oxygen atoms and tWo 
coordinate covalent nitrogen atoms. There are many Ways in 
Which such a coordinate environment can be provided. Salen 
ligands are readily illustrative of a simple, inexpensive 
means of providing such an environment. 
In accordance With yet another aspect of the present 
invention a composition is provided for cleaving phosphate 
ester bonds. The composition comprises an effective amount 
of an active agent selected from a group of compounds 
consisting of R 
But tBu But tBu 
Wherein R:alkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a counteranion and a compatible 
solvent. 
Alternatively the composition for cleaving phosphate 
ester bonds may be described as comprising an effective 
amount of an active agent selected from a group of com 




o/ | \o 
Y 
But tBu But tBu 
Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
X:aluminum, gallium, indium or thallium and Y:a halide, 
a chlorate or a nitrate and a compatible solvent. 
In still another alternative, the composition for cleaving 
phosphate ester bonds may be described as comprising an 
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effective amount of an active agent selected from a group of 
compounds consisting of a general formula (LX)nY Wherein 
X is selected from a group consisting of aluminum, gallium, 
indium and thallium; Y is selected from a group consisting 
of a halide, a chlorate, a sulfate and a nitrate; and L is a 
chelating ligand containing tWo nitrogen and tWo oxygen 
donor groups Where n:l or 2; and a compatible solvent. 
In accordance With yet another aspect of the present 
invention, a method is provided for cleaving a phosphate 
ester bond. The method comprises reacting a phosphate ester 
bond containing compound With an active agent selected 
from a group of compounds consisting of 
But 
Wherein R:alkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a potential counteranion. 
Alternatively, the method may be described as comprising 
the step of reacting a phosphate ester bond containing 
compound With an active agent selected from a group of 




o/ | \o 
Y 
But tBu But tBu 
Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
X:aluminum, gallium, indium or thallium and Y:a halide, 
a chlorate or a nitrate. 
Still further the method for cleaving a phosphate ester 
bond may be alternatively described as comprising reacting 
a phosphate ester bond containing compound With an active 
agent selected from a group of compounds consisting of a 
general formula (LX)nY Wherein X is selected from a group 
consisting of aluminum, gallium, indium and thallium; Y is 
selected from a group consisting of a halide, a chlorate, a 
sulfate and a nitrate; and L is a chelating ligand containing 
tWo nitrogen and tWo oxygen donor groups Where n:l or 2. 
In accordance With still another aspect of this invention, 
a catalytic method for dealkylation of a phosphate ester bond 











ester bond containing compound With an active agent 




o/ | \o 
Y 
But tBu But tBu 
Wherein R:alkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a potential counteranion in the 
presence of BBr3. 
Alternatively, the catalytic method of dealkylation of a 
phosphate ester bond containing compound may be de?ned 
as comprising reacting the phosphate ester bond containing 
compound With an active agent selected from a group of 




o/ | \o 
Y 
But tBu But tBu 
Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
X:aluminum, gallium, indium or thallium and Y:a halide, 
a chlorate or a nitrate in the presence of BBr3. 
In accordance With still another alternative, a method of 
cleaving a phosphate ester bond may be described as com 
prising reacting a phosphate ester bond containing com 
pound With an active agent selected from a group of com 
pounds consisting of a general formula (LX)nY Wherein X 
is selected from a group consisting of aluminum, gallium, 
indium and thallium; Y is selected from a group consisting 
of a halide, a chlorate, a sulfate and a nitrate; and L is a 
chelating ligand containing tWo nitrogen and tWo oxygen 
donor groups (Where n:l or 2) in the presence of BBr3. 
DETAILED DESCRIPTION OF THE 
INVENTION 
A neW class of compounds has been developed that can 
serve as stoichiometric or catalytic reagents for the breaking 
of phosphate ester bonds. The compounds can be Written as 
the general formula (LX)nY Where X is selected from a 
group consisting of aluminum, gallium, indium and thal 
lium, Y is selected from a group consisting of a halide, a 
chlorate, a sulfate and a nitrate and L is a chelating ligand 
containing tWo nitrogen and tWo oxygen donor groups 
Where n:l or 2. 
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More speci?cally, the compounds may be described as 
having the structural formula 
But 
Wherein RIalkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a counteranion. Typically, Where 
RIalkyl, the alkyl has betWeen 2 and 8 carbon atoms. Still 
more speci?cally describing the invention, R;(CH2)2i, 
i(CH2)3i and a phenyl group, XIaluminum, gallium, 
indium or thallium and Y:a halide, a chlorate or a nitrate. 
Particularly useful embodiments of the compounds of the 
present invention include but are not limited to: 
N N 
Al 
0/ | \o 
Br 
But tBu But tBu 
salen(‘Bu)AlBr 
N N 
/ \ \Al/ 
Br 
But But tBu 
salpen(‘Bu)AlBr 
N N 
/ \ \Al/ 
0/ | \o 
Br 
But tBu But tBu 
salophen(‘Bu)AlBr 
In the compounds, one group 13 element capable of 
?ve-coordinate geometry is bound by a ligand containing 
tWo nitrogen and tWo oxygen donor groups and a counter 
anion. When combined With a molecule containing a phos 
phate ester bond (iPiO4Ci) the compounds undergo 












the carbon atom of the phosphate ester bond (4OiCi). 
The cleaved phosphate can be removed by addition of boron 
bromide. This also regenerates the original compounds and 
thereby renders the process catalytic. 
The breaking of a phosphate ester bond is a critical step 
in the destruction of nerve agents such as 
O 
O 






Such an approach is also useful in destroying other biologi 
cally active agents or organic reagents incorporating a 
phosphate ester bond. 
The compounds of the present invention are relatively 
easily prepared by the redistribution of (a) (C2H5)3X 
Wherein XIaluminum, gallium, indium or thallium and (b) 
XY3 Where XIaluminum, gallium, indium, or thallium and 
Y:a counteranion such as a halide, a chlorate, a sulfate or a 
nitrate in toluene to produce in situ (C2H5)2XY. A solution 
of R(tBu)H2, Where RIalkyl, aryl or alkylaryl (e.g. salen 
(’Bu)H2, salpen(’Bu)H2 and salophen(’Bu)H2), in toluene is 
then transferred to the reaction mixture. The reaction mix 
ture is then re?uxed and ?ltered and dried to produce the 
compounds of the present invention. 
Compound (LX)nY, Where YIchlorate, sulfate or nitrate, 
may be prepared by stirring (LX)nY, Where Y:a halide, With 
NaClO3, NaZSO4 or NaNO3 respectively. 
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In addition to the novel compounds described above, the 
present invention also relates to novel compositions com 
prising those novel compounds in a compatible solvent. 
Compatible solvents include but are not limited to chloro 
form, toluene, methylene chloride, tetrahydrofuran and mix 
tures thereof. 
Still further, the present invention relates to a method for 
cleaving a phosphate ester bond. That method comprises 
reacting a phosphate ester bond containing compound With 
an active agent selected from the compounds or composi 
tions of the present invention. 
Further, a catalytic method for dealkylation of a phos 
phate ester bond comprises reacting a phosphate ester bond 
containing compound With an active agent selected from a 
compound or composition of the present invention in the 
presence of boron bromide (BBr3). 
The folloWing syntheses and examples are presented to 
further illustrate the invention, but the invention is not to be 
considered as limited thereto. In the examples, all air 
sensitive manipulations Were conducted using standard 
bench-top Schlenk line technique in conjunction With an 
inert atmosphere glove box. All solvents Were rigorously 
dried prior to use. All glassWare Was cleaned With a base and 
an acid Wash and dried in an oven at 1300 C. overnight prior 
to use. The ligands salen(tBu)H2, salpen(’Bu)H2 and 
salophen(’Bu)H2) Were synthesiZed according to the litera 
ture procedure (see, for example, L. Deng, E. N. Jacobsen, 
J. Org. Chem. 1992, 57, 4320) All other starting materials 
Were obtained from Sigma Aldrich. NMR data Were 
obtained on Varian Gemini-200 and Varian VXR-400 instru 
ments. Chemical shifts Were reported relative to SiMe4 for 
1H and 13C and AlCl3 in D20 for 27Al and are reported in 
ppm. Infrared transmission spectra Were recorded at room 
temperature using the potassium bromide pellet technique 
on a Fourier-transform Magna-IR ESP 560 spectrometer. 
EXAMPLE 1 
Synthesis of salen(tBu)AlBr 
To a rapidly stirred solution of Et2AlBr in toluene, pre 
pared in situ by the redistribution of triethyl aluminum (0.42 
g, 3.60 mmol) and aluminum(III) bromide (1M solution in, 
dibromomethane 1.8 mL, 1.80 mmol), a solution of salen 
(zBu)H2 (2.69 g, 5.46 mmol) in toluene Was cannula trans 
ferred. The reaction mixture Was re?uxed for 8 hours and 
?ltered. The volatiles Were removed under vacuum from the 
clear yelloW ?ltrate to give a yelloW microcrystalline solid 
Which Was puri?ed by recrystallization from toluene. Single 
crystals suitable for X-ray analysis Were groWn from sloW 
diffusion of hexane vapor into a concentrated CH2Cl2 solu 
tion of salen(tBu)AlBr. Yield: 2.69 g (73.8%). Mp: 
33(L332o C. (dec.). 1H NMR (CDCl3): 6 1.33 (s, 18H, 
C(CH3)3), 1.57 (s, 18H, C(CH3)3), 3.97 (m, 4H, NCHZ), 
7.08 (d, 2H, PhH), 7.60 (d, 2H, PhH), 8.40 (s, 2H, N=CH); 
13C NMR (CDCl3): 6 29.7 C(CH3)3), 31.3 (C(CH3)3), 34.0 
(CCH3)3), 35.5 (CCH3)3), 54.5 (NCH2), 118.2 (Ph), 127.3 
(Ph), 131.6 (Ph), 139.1 (Ph), 141.3 (Ph), 162.7 (Ph), 170.4 
(NCH); 27Al NMR (CDCl3): 6 38 (Wl/2:5183 HZ). IR 
v/cm_l: 2962 m, 2905 W, 2866 W, 1648 s, 1628 s, 1544 m, 
1475 m, 1444 m, 1421 W, 1390 W, 1361 W, 1310 W, 1257 W, 
1180 W, 867 W, 845 m, 816 W, 786 W, 756 W, 608 m, 586 W. 














Synthesis of salpen(tBu)AlBr 
To a rapidly stirred solution of Et2AlBr in toluene, pre 
pared in situ by the redistribution of triethyl aluminum (0.24 
g, 2.08 mmol) and aluminum(III) bromide (1M solution in, 
dibromomethane 1.0 mL, 1.00 mmol), a solution of salpen 
(tBu)H2 (1.57 g, 3.10 mmol) in toluene Was cannula trans 
ferred. The reaction mixture Was re?uxed for 17 hours. The 
cloudy yelloW solution Was concentrated under vacuum to 
about one third of its volume. The yelloW precipitate Was 
isolated by cannula ?ltration, Washed With ~15 mL of 
hexane, dried under vacuum and recrystallized from toluene. 
X-ray quality crystals Were groWn from sloW diffusion of 
hexane vapor into a concentrated CH2Cl2 solution of salpen 
(’Bu)AlBr. Yield: 1.04 g (55%). Mp: 334340 C. (dec.). 1H 
NMR (CDCl3): 6 1.30 (s, 18H, C(CH3)3), 1.50 (s, 18H, 
C(CH3)3), 2.23 (m, 2H, CH2CH2CH2), 3.85 (m, 4H, NCHZ), 
7.07 (d, 2H, PhiH), 7.56 (d, 2H, PhiH), 8.29 (s, 2H, 
N=CH); 13C NMR (CDCl3): 6 27.2 (CH2), 29.7 (C(CH3)3), 
31.3 (C(CH3)3), 33.9 (CCH3)3), 35.4 (CCH3)3), 55.1 
(NCH2), 118.1 (Ph), 127.2 (Ph), 131.4 (Ph), 138.9 (Ph), 
141.0 (Ph), 162.5 (Ph), 172.0 (N=CH); 27Al NMR 
(CDCl3): 6 36 (WI/2I3339 HZ). IR v/cm_l: 2956 m, 2906 W, 
2866 W, 1642 s, 1624 s, 1548 m, 1463 s, 1418 m, 1390 W, 
1361 m, 1312 m, 1259 m,1180 m, 1097 W, 863 m, 847 m, 
784 W, 755 W, 601 m. MS (EI, positive): 531 (M+iBr, 
100%). 
EXAMPLE 3 
Synthesis of salophen(’Bu)AlBr 
To a rapidly stirred solution of Et2AlBr in toluene, pre 
pared in situ by the redistribution of triethyl aluminum (0.21 
g, 1.08 mmol) and aluminum(III) bromide (1M solution in 
dibromomethane, 0.90 mL, 0.90 mmol), a solution of 
salophen(zBu)H2 (1.46 g, 2.70 mmol) in toluene Was cannula 
transferred. The golden yelloW solution Was re?uxed for 15 
hours. Then it Was concentrated under vacuum to about one 
third of its volume. YelloW crystals precipitated after cooling 
at —30° C. for 24 hours. The crystals Were isolated by 
cannula ?ltration, Washed With hexane and dried under 
vacuum. Yield: 1.54 g (88%). Mp: 3200 C. (dec.). 1H NMR 
(CDCl3): 6 1.37 (s, 18H, C(CH3)3), 1.63 (s, 18H, C(CH3)3), 
7.24 (d, 2H, PhiH), 7.35 (m, 2H, PhiH), 7.66 (m, 2H, 
PhiH), 7.71 (d, 2H, PhiH), 8.94 (s, 2H, N=CH); 13C 
NMR (CDCl3): 6 29.8 (C(CH3)3), 31.2 (C(CH3)3), 34.1 
(C(CH3)3), 35.6 (C(CH3)3), 115.4 (Ph), 115.7 (Ph), 118.5 
(Ph), 126.7 (Ph), 127.5 (Ph), 128.2 (Ph), 129.1 (Ph), 133.2 
(Ph), 137.5 (Ph), 139.8 (Ph), 141.6 (Ph), 161.2 (Ph), 162.4 
(Ph), 164.1 (N=CH); 27Al NMR (CDCl3): 6 32 (Wl/2:5183 
HZ). IR (KBR) v/cm_l: 2961 s, 2905 W, 2868 W, 1621 s, 
1554 m, 1542 s, 1469 s, 1474 m, 1445 m, 1420 m, 1391 Wm, 
1361 s, 1311 m, 1255 m, 1202 W, 1179 W, 865 W, 847 m, 786 
W, 757 W, 610 m. MS (EI, positive): 646 (M", 13%), 565 




In a vial 30 mg (0.05 mmol) salen(t)AlBr Was dissolved 
in about 1 mL CDCl3. The solution Was transferred to a 
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NMR tube in Which trimethyl phosphate (1.96 uL, 0.017 
mmol, density 1.197 g/mL) Was added With a syringe. The 
mixture Was shaken and monitored by 1H NMR. The % 
dealkylation Was calculated from the peak integrations of 
methyl bromide produced and unchanged phosphate. 
B.) Salpen(tBu)AlBr 
In a vial 30 mg (0.05 mmol) salpen(t)AlBr Was dissolved 
in about 1 mL CDCl3. The solution Was transferred to a 
NMR tube in Which trimethyl phosphate (1.91 uL, 0.016 
mmol, density 1.197 g/mL) Was added With a syringe. The 
mixture Was shaken and monitored by 1H NMR. The % 
dealkylation Was calculated from the peak integrations of 
methyl bromide produced and unchanged phosphate. 
C.) Salophen(’Bu)AlBr 
In a vial 30 mg (0.05 mmol) salophen(t)AlBr Was dis 
solved in about 1 mL CDCl3. The solution Was transferred 
to a NMR tube in Which trimethyl phosphate (1.81 uL, 0.015 
mmol, density 1.197 g/mL) Was added With a syringe. The 
mixture Was shaken and monitored by 1H NMR. The % 
dealkylation Was calculated from the peak integrations of 
methyl bromide produced and unchanged phosphate. 
TABLE 1 
% Dealkylationm of trimethyl phosphate (TMP) and tributyl 
phosphate (TBP) With SalenCBu)AlBr compounds. 
Salen Salpen Salophen 
(‘Bu)AlBr (‘Bu)AlBr (‘Bu)AlBr 
Compound TMP TBP TMP TBP TMP TBP 
30 minutes 64 12 35 7 18 100 
2 hours 79 100 44 100 30 100 
4 hours 89 100 44 100 40 100 
6 hours 91 5 6 46 
8 hours 93 5 8 5 8 
10 hours 95 62 64 
12 hours 9 6 67 69 
24 hours 96 100 69 100 85 100 
[“]Calculated from the integration of 1H NMR spectra of methyl bromide 
produced and unchanged trimethyl phosphate at room temperature in 
CDCl3. In CD3OD after 24 hours salen(‘Bu)AlBr shoWed no dealkylation 
While salpen(‘Bu)AlBr and salophen(‘Bu)AlBr had 4% and 3% dealkyla 




In a vial 15 mg (0.025 mmol) salen(t)AlBr Was dissolved 
in about 1 mL CDCl3. The solution Was transferred to a 
NMR tube in Which trimethyl phosphate (29.30 uL, 0.25 
mmol, density 1.197 g/mL) and boron tribromide (0.25 mL, 
0.25 mmol, 1M solution in hexane) Were added With a 
syringe. The mixture Was shaken and monitored by 1H 
NMR. The % dealkylation Was calculated from the peak 
integrations of methyl bromide produced and unchanged 
phosphate. 
B.) Salpen(tBu)AlBr 
In a vial 15 mg (0.025 mmol) salpen(t)AlBr Was dissolved 
in about 1 mL CDCl3. The solution Was transferred to a 
NMR tube in Which trimethyl phosphate (28.65 uL, 0.25 
mmol, density 1.197 g/mL) and boron tribromide (0.25 mL, 
0.25 mmol, 1M solution in hexane) Were added With a 












NMR. The % dealkylation Was calculated from the peak 
integrations of methyl bromide produced and unchanged 
phosphate. 
C.) Salophen(tBu)AlBr 
In a vial 15 mg (0.023 mmol) salophen(t)AlBr Was 
dissolved in about 1 mL CDCl3. The solution Was trans 
ferred to a NMR tube in Which trimethyl phosphate (27.15 
uL, 0.23 mmol, density 1.197 g/mL) and boron tribromide 
(0.23 mL, 0.23 mmol, 1M solution in hexane) Were added 
With a syringe. The mixture Was shaken and monitored by 
1H NMR. The % dealkylation Was calculated from the peak 
integrations of methyl bromide produced and unchanged 
phosphate. 
D.) Control: BBr3 
In an NMR tube containing about 1 mL CDCl3, trimethyl 
phosphate (29.30 uL, 0.25 mmol, density 1.197 g/mL) and 
boron tribromide (0.25 mL, 0.25 mmol, 1M solution in 
hexane) Were added With a syringe. The mixture Was shaken 
and monitored by 1H NMR. The % dealkylation Was cal 
culated from the peak integrations of methyl bromide pro 
duced and unchanged phosphate. 
TABLE 2 
Catalytic dealkylation of trimethyl phosphate (TMP) With 
Salen(‘Bu)AlBr compounds. Numbers represent % dealkvlationm 
1 + 2 + 3 + 
TMP + BBr3 TMP + BBr3 TMP + BBr3 TMP + BBr3 
Compound (1:10:10) (1:10:10) (1:10:10) (1:1) 
30 minutes 88 78 82 58 
2 hours 100 92 84 67 
6 hours 100 100 95 67 
24 hours 100 100 95 81 
[alcalculated from the integration of 1H NMR spectra of methyl bromide 
produced and unchanged trimethyl phosphate at room temperature in 
CDCl3. l = salen(‘Bu)AlBr, 2 = salpen(‘Bu)AlBr, 3 = salophen(‘Bu)AlBr. 
EXAMPLE 6 
Synthesis of Salen Aluminum Nitrate 
The product of Example 1 is subjected to an anion 
exchange reaction. Speci?cally, salen(tBu)AlBr is stirred 
With sodium nitrate in 1:1 ratio in ethanol to produce 
salen(’Bu)AlNO3. 
EXAMPLE 7 
Synthesis of Salpen Aluminum Sulfate 
The product of Example 2 is subjected to an anion 
exchange reaction. Speci?cally, salpen(tBu)AlBr is stirred 
With sodium sulfate in 2:1 ratio in ethanol to produce 
(salpen(tBu)Al)2SO4. 
EXAMPLE 8 
Synthesis of Salophen Aluminum Chlorate 
The product of Example 3 is subjected to an anion 
exchange reaction. Speci?cally, salophen(tBu)AlBr is stirred 
With sodium chlorate in 1:1 ratio in ethanol to produce 
salophen(tBu)AlClO3. 
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EXAMPLE 9 
Preparation of Gallium, Indium and Thallium 
Compounds of the Present Invention 
Gallium, indium or thallium are substituted for aluminum 
in the starting materials of examples 1, 2 or 3. 
EXAMPLE 10 
Preparation of Salen(tBu)AlCl and 
Salophen(tBu)AlCl 
These compounds are prepared by alkane elimination 
betWeen the Salen(’Bu)H2 or Salophen(’Bu)H2 ligand and 
dialkylaluminum chloride. 
The foregoing description of a preferred embodiment of 
the present invention has been presented for purposes of 
illustration and description. It is not intended to be exhaus 
tive or to limit the invention to the precise form disclosed. 
Obvious modi?cations or variations are possible in light of 
the above teachings. 
The embodiment Was chosen and described to provide the 
best illustration of the principles of the invention and its 
practical application to thereby enable one of ordinary skill 
in the art to utiliZe the invention in various embodiments and 
With various modi?cations as are suited to the particular use 
contemplated. All such modi?cations and variations are 
Within the scope of the invention as determined by the 
appended claims When interpreted in accordance With the 
breadth to Which they are fairly, legally and equitably 
entitled. The draWings and preferred embodiments do not 
and are not intended to limit the ordinary meaning of the 
claims and their fair and broad interpretation in any Way. 
What is claimed is: 
1. A method of cleaving a phosphate ester bond, com 
prising: 
reacting a phosphate ester bond containing compound 
With an active agent selected from a group of com 
pounds consisting of 
But tBu But tBu 
Wherein RIalkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a counteranion. 
2. A method of cleaving a phosphate ester bond, com 
prising: 
reacting a phosphate ester bond containing compound 
With an active agent selected from a group of com 











Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
XIaluminum, gallium, indium or thallium and Y:a 
halide, a chlorate or a nitrate. 
3. A catalytic method for dealkylation of a phosphate ester 
bond containing compound, comprising 
reacting said phosphate ester bond containing compound 
With an active agent selected from a group of com 
pounds consisting of 
But 
Wherein RIalkyl, aryl or alkylaryl, X:a group 13 element 
other than boron and Y:a counteranion in the presence 
of BBr3. 
4. A catalytic method for dealkylation of a phosphate ester 
bond containing compound, comprising 
reacting said phosphate ester bond containing compound 
With an active agent selected from a group of com 
pounds consisting of 
But tBu But 
Wherein R;(CH2)2i, i(CH2)3i and a phenyl group, 
XIaluminum, gallium, indium or thallium and Y:a 
halide, a chlorate or a nitrate in the presence of BBr3. 
5. A method for cleaving a phosphate ester bond, com 
prising: 
reacting a phosphate ester bond containing compound 
With an active agent selected from a group of com 
pounds consisting of a general formula (LX)nY 
Wherein: 
X is selected from a group consisting of aluminum, 
gallium, indium and thallium; 
Y is selected from a group consisting of a halide, a 
chlorate, a sulfate and a nitrate; and 
L is a chelating ligand containing tWo nitrogen and tWo 
oxygen donor groups, Where n:l or 2. 
6. The method of claim 5 further including adding BBr3. 
* * * * * 
